FDA at BIO 2011 - Weighing a hefty mission: Where is the balance?

Author： Levy Suzanne  

Publisher： Palgrave Macmillan Ltd

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.17, Iss.4, 2011-11, pp. : 365-366

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Riposte: FDA response to ‘Yin, yang and the biopharmaceutical industry’

By Rosenberg Amy S  

Journal of Commercial Biotechnology, Vol. 10, Iss. 1, 2003-09 ,pp. : 36-39

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Weighing a single atom using a coupled plasmon–carbon nanotube system

By  

Science and Technology of Advanced Materials, Vol. 13, Iss. 2, 2012-04 ,pp. : 65-70

IOP Publishing

Access to resources Recommend Favorite

Analyzing United States Prescribing Information to gain insight into FDA-sponsor discussions

By Daizadeh Iraj  

Journal of Commercial Biotechnology, Vol. 17, Iss. 3, 2011-08 ,pp. : 218-229

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Welcome to NanoBio Euro 2005

By  

Nanobiotechnology, Vol. 1, Iss. 3, 2005-09 ,pp. : 253-254

Humana Press, Inc

Access to resources Recommend Favorite

NanoBio Euro 2005 Abstracts

By  

Nanobiotechnology, Vol. 1, Iss. 3, 2005-09 ,pp. : 255-322

Humana Press, Inc

Access to resources Recommend Favorite